192 related articles for article (PubMed ID: 29932317)
1. [Lead compound optimization strategy(5) – reducing the hERG cardiac toxicity in drug development].
Zhou SB; Wang J; Liu H
Yao Xue Xue Bao; 2016 Oct; 51(10):1530-9. PubMed ID: 29932317
[TBL] [Abstract][Full Text] [Related]
2. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
3. The hERG potassium channel as a therapeutic target.
Witchel HJ
Expert Opin Ther Targets; 2007 Mar; 11(3):321-36. PubMed ID: 17298291
[TBL] [Abstract][Full Text] [Related]
4. Predicting drug-hERG channel interactions that cause acquired long QT syndrome.
Sanguinetti MC; Mitcheson JS
Trends Pharmacol Sci; 2005 Mar; 26(3):119-24. PubMed ID: 15749156
[TBL] [Abstract][Full Text] [Related]
5. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.
Zünkler BJ
Pharmacol Ther; 2006 Oct; 112(1):12-37. PubMed ID: 16647758
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in computational prediction of HERG blockage.
Wang S; Li Y; Xu L; Li D; Hou T
Curr Top Med Chem; 2013; 13(11):1317-26. PubMed ID: 23675938
[TBL] [Abstract][Full Text] [Related]
7. The hERG K+ channel: target and antitarget strategies in drug development.
Raschi E; Vasina V; Poluzzi E; De Ponti F
Pharmacol Res; 2008 Mar; 57(3):181-95. PubMed ID: 18329284
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
9. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
10. SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Liu H; Yang L; Chen KH; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
Pharmacol Res; 2016 Feb; 104():61-9. PubMed ID: 26689773
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias.
Potet F; Lorinc AN; Chaigne S; Hopkins CR; Venkataraman R; Stepanovic SZ; Lewis LM; Days E; Sidorov VY; Engers DW; Zou B; Afshartous D; George AL; Campbell CM; Balser JR; Li M; Baudenbacher FJ; Lindsley CW; Weaver CD; Kupershmidt S
J Biol Chem; 2012 Nov; 287(47):39613-25. PubMed ID: 23033485
[TBL] [Abstract][Full Text] [Related]
12. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
[TBL] [Abstract][Full Text] [Related]
13. Support vector machines classification of hERG liabilities based on atom types.
Jia L; Sun H
Bioorg Med Chem; 2008 Jun; 16(11):6252-60. PubMed ID: 18448342
[TBL] [Abstract][Full Text] [Related]
14. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
De Bruin ML; Pettersson M; Meyboom RH; Hoes AW; Leufkens HG
Eur Heart J; 2005 Mar; 26(6):590-7. PubMed ID: 15637086
[TBL] [Abstract][Full Text] [Related]
15. Computational investigations of hERG channel blockers: New insights and current predictive models.
Villoutreix BO; Taboureau O
Adv Drug Deliv Rev; 2015 Jun; 86():72-82. PubMed ID: 25770776
[TBL] [Abstract][Full Text] [Related]
16. hERG potassium channels and cardiac arrhythmia.
Sanguinetti MC; Tristani-Firouzi M
Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
[TBL] [Abstract][Full Text] [Related]
17. Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties.
Polak S; Wiśniowska B; Brandys J
J Appl Toxicol; 2009 Apr; 29(3):183-206. PubMed ID: 18988205
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced hERG block and long QT syndrome.
Witchel HJ
Cardiovasc Ther; 2011 Aug; 29(4):251-9. PubMed ID: 20406244
[TBL] [Abstract][Full Text] [Related]
19. A temperature-dependent in silico model of the human ether-à-go-go-related (hERG) gene channel.
Li Z; Dutta S; Sheng J; Tran PN; Wu W; Colatsky T
J Pharmacol Toxicol Methods; 2016; 81():233-9. PubMed ID: 27178106
[TBL] [Abstract][Full Text] [Related]
20. BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heart.
Qu Y; Fang M; Gao B; Chui RW; Vargas HM
J Pharmacol Exp Ther; 2011 Apr; 337(1):2-8. PubMed ID: 21205913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
